Cited by 650Lipoproteins and Cardiovascular HealthGenetic Associations and EpidemiologyLipid metabolism and disorders

Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction

Open access
Do, Ron, Stitziel, Nathan O., Won, Hong-Hee, Jørgensen, Anders Berg, Duga, Stefano, Angelica Merlini, Pier, Kiezun, Adam, Farrall, Martin +86 more·2015·Nature

Abstract

Myocardial infarction (MI), a leading cause of death around the world, displays a complex pattern of inheritance. When MI occurs early in life, genetic inheritance is a major component to risk. Previously, rare mutations in low-density lipoprotein (LDL) genes have been shown to contribute to MI risk in individual families, whereas common variants at more than 45 loci have been associated with MI risk in the population. Here we evaluate how rare mutations contribute to early-onset MI risk in the population. We sequenced the protein-coding regions of 9,793 genomes from patients with MI at an early age (≤50 years in males and ≤60 years in females) along with MI-free controls. We identified two genes in which rare coding-sequence mutations were more frequent in MI cases versus controls at exome-wide significance. At low-density lipoprotein receptor (LDLR), carriers of rare non-synonymous mutations were at 4.2-fold increased risk for MI; carriers of null alleles at LDLR were at even higher risk (13-fold difference). Approximately 2% of early MI cases harbour a rare, damaging mutation in LDLR; this estimate is similar to one made more than 40 years ago using an analysis of total cholesterol. Among controls, about 1 in 217 carried an LDLR coding-sequence mutation and had plasma LDL cholesterol > 190 mg dl(-1). At apolipoprotein A-V (APOA5), carriers of rare non-synonymous mutations were at 2.2-fold increased risk for MI. When compared with non-carriers, LDLR mutation carriers had higher plasma LDL cholesterol, whereas APOA5 mutation carriers had higher plasma triglycerides. Recent evidence has connected MI risk with coding-sequence mutations at two genes functionally related to APOA5, namely lipoprotein lipase and apolipoprotein C-III (refs 18, 19). Combined, these observations suggest that, as well as LDL cholesterol, disordered metabolism of triglyceride-rich lipoproteins contributes to MI risk.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nature13917

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 55 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Do, R., Stitziel, N. O., Won, H.-H., Jørgensen, A. B., Duga, S., Angelica Merlini, P., Kiezun, A., Farrall, M., Goel, A., Zuk, O., Guella, I., Asselta, R., Lange, L. A., Peloso, G. M., Auer, P. L., NHLBI Exome Sequencing Project, Girelli, D., Martinelli, N., Farlow, D. N., DePristo, M. A., Roberts, R., Stewart, A. F. R., Saleheen, D., Danesh, J., Epstein, S. E., Sivapalaratnam, S., Kees Hovingh, G., Kastelein, J. J., Samani, N. J., Schunkert, H., Erdmann, J., Shah, S. H., Kraus, W. E., Davies, R., Nikpay, M., Johansen, C. T., Wang, J., Hegele, R. A., Hechter, E., Marz, W., Kleber, M. E., Huang, J., Johnson, A. D., Li, M., Burke, G. L., Gross, M., Liu, Y., Assimes, T. L., Heiss, G., Lange, E. M., Folsom, A. R., Taylor, H. A., Olivieri, O., Hamsten, A., Clarke, R., Reilly, D. F., Yin, W., Rivas, M. A., Donnelly, P., Rossouw, J. E., Psaty, B. M., Herrington, D. M., Wilson, J. G., Rich, S. S., Bamshad, M. J., Tracy, R. P., Adrienne Cupples, L., Rader, D. J., Reilly, M. P., Spertus, J. A., Cresci, S., Hartiala, J., Wilson Tang, W. H., Hazen, S. L., Allayee, H., Reiner, A. P., Carlson, C. S., Kooperberg, C., Jackson, R. D., Boerwinkle, E., Lander, E. S., Schwartz, S. M., Siscovick, D. S., McPherson, R., Tybjaerg-Hansen, A., Abecasis, G. R., Watkins, H., Nickerson, D. A., Ardissino, D., Sunyaev, S. R., O'Donnell, C. J., Altshuler, D., Gabriel, S., & Kathiresan, S.
Affiliations
  • Broad Institute (US)
  • Washington University in St. Louis (US)
  • University of Copenhagen (DK)
  • University of Milan (IT)
  • Centre for Human Genetics (GB)
  • University of North Carolina at Chapel Hill (US)
  • Fred Hutch Cancer Center (US)
  • University of Verona (IT)
  • Ottawa Heart Institute (CA)
  • University of Cambridge (GB)
  • Amsterdam UMC Location University of Amsterdam (NL)
  • University of Leicester (GB)
  • German Centre for Cardiovascular Research (DE)
  • Duke University (US)
  • Western University (CA)
  • Heidelberg University (DE)
  • National Heart, Lung, and Blood Institute (US)
  • University of Alabama at Birmingham (US)
  • University of Minnesota (US)
  • Stanford Medicine (US)
  • Karolinska Institutet (SE)
  • Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
  • Group Health Cooperative (US)
  • University of Mississippi Medical Center (US)
  • Seattle Children's Hospital (US)
  • University of Vermont (US)
  • Boston University (US)
  • University of Pennsylvania (US)
  • University of Missouri–Kansas City (US)
  • University of Southern California (US)
  • University of Washington (US)
  • The Ohio State University (US)
Venue
Nature
Published
2014-12-10
Volume
518
Issue
7537
Pages
102-106
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2050838276
Cited by
650
References
55
Citations by year
2026: 22 · 2025: 14 · 2024: 29 · 2023: 30 · 2022: 50 · 2021: 42 · 2020: 64 · 2019: 68 · 2018: 63 · 2017: 87 · 2016: 111 · 2015: 65 · 2014: 2
FWCI
87.31
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Funders
  • Massachusetts General Hospital (R01HL107816)
  • Cleveland Clinic
  • Foundation for Barnes-Jewish Hospital
  • Donovan Family Foundation
  • Wellcome Trust (095552, 090532)
  • National Institute for Health and Care Research (NF-SI-0512-10165, NF-SI-0611-10170, NF-SI-0508-10235)
  • British Heart Foundation (RG/08/014/24067)
  • Parkinson's UK (G-0907)
  • Fondation Leducq (T32HL007208)
  • National Institutes of Health (1s10od020069-01, 1rc2hl103010-01, UL1TR000439, HL076491)
  • Canadian Institutes of Health Research
  • Medical Research Council (MR/L003120/1)
  • National Institute on Aging (P30AG010129, R01AG033193)
  • National Heart, Lung, and Blood Institute (HL 102923, RC2HL102925, HL-102924, K08HL114642, RC2HL102926, RC2HL102923, RC2HL-103010, HL 103010, P01HL076491, P01HL098055, RC2HL102924, T32HL00720, R01HL107816, T32HL007208, T32HL007604)
  • National Human Genome Research Institute (U54HG003067)
  • National Institute of Nursing Research (R01NR013396)
  • National Institute of Neurological Disorders and Stroke (R01NS017950)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords
early-onset myocardial infarction, LDL receptor, APOA5, rare variants, apolipoprotein A-V, LDL cholesterol, triglycerides, triglyceride-rich lipoproteins, genetic risk, exome sequencing, null alleles, cardiovascular genetics, familial hypercholesterolemia
MeSH terms
Apolipoprotein A-V, Age Factors, Alleles, Apolipoproteins A, Coronary Artery Disease, Female, Genetics, Population, Heterozygote, Humans, Cholesterol, LDL, Male, Middle Aged, Mutation, Myocardial Infarction, Receptors, LDL, Triglycerides, United States, Case-Control Studies, Age of Onset, Genetic Predisposition to Disease, National Heart, Lung, and Blood Institute (U.S.), Exome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review